A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma
A phase 3 trial testing Purinostat in diffuse large B-cell lymphoma, now recruiting.
Overview
A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma is a phase 3 interventional study registered as NCT07011056, led by Chengdu Zenitar Biomedical Technology, and recruiting when checked on 2026-09-11. Official title: A Randomised, Controlled, Multicenter Phase III Clinical Study Evaluating the Efficacy and Safety of the Purinostat Mesylate for Injection (PM) Compared to Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL). Planned enrolment is 390 participants (estimated). The study started in 2025-07-18 and primary completion is expected in 2029-06-30. No results have been posted on ClinicalTrials.gov.
Similar pages
not linked directly; found by shared links- TrialStudy Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Shares Diffuse large B-cell lymphoma and the tag ctgov-ingest.
- TrialAZD0486 1L Therapy for Elderly or Unfit Participants With LBCL
Shares Diffuse large B-cell lymphoma and the tag ctgov-ingest.
- TrialA Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma
Shares Diffuse large B-cell lymphoma and the tag ctgov-ingest.
- TrialA Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Shares Diffuse large B-cell lymphoma and the tag ctgov-ingest.
- TrialA Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
Shares Diffuse large B-cell lymphoma and the tag ctgov-ingest.
- TrialA Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Shares Diffuse large B-cell lymphoma and the tag ctgov-ingest.
- TreatmentTC011
Shares Diffuse large B-cell lymphoma and the tag ctgov-ingest.
- TreatmentCRC01
Shares Diffuse large B-cell lymphoma and the tag ctgov-ingest.